REV-ERB Agonists Block Autophagy in Cancer Cells

Area of Science:

• Chronobiology
• Cancer Biology
• Molecular Oncology

Background:

• The circadian clock regulates numerous cellular processes.
• Disruptions in circadian rhythms are linked to cancer development and progression.
• Key clock components are potential targets for cancer therapy.

Purpose of the Study:

• To investigate the impact of disrupting circadian clock components on cancer cell viability.
• To explore the therapeutic potential of targeting circadian clock mechanisms in cancer.

Main Methods:

• Utilized *in vitro* cell culture models.
• Employed *in vivo* preclinical cancer models.
• Assessed cancer cell viability following manipulation of circadian clock genes/proteins.

Main Results:

• Disruption of specific circadian clock components significantly reduced cancer cell viability in both *in vitro* and *in vivo* settings.
• Targeting the circadian clock demonstrated a direct negative effect on tumor cell survival and proliferation.

Conclusions:

• Circadian clock components are critical for cancer cell survival.
• Targeting the circadian clock represents a promising strategy for novel cancer therapies.